Financials data is unavailable for this security.
View more
Year on year Terumo Corp grew revenues 12.39% from 820.21bn to 921.86bn while net income improved 19.09% from 89.33bn to 106.37bn.
Gross margin | 52.74% |
---|---|
Net profit margin | 12.20% |
Operating margin | 16.07% |
Return on assets | 6.65% |
---|---|
Return on equity | 8.98% |
Return on investment | 7.95% |
More ▼
Cash flow in JPYView more
In 2024, Terumo Corp increased its cash reserves by 9.37%, or 17.56bn. The company earned 146.33bn from its operations for a Cash Flow Margin of 15.87%. In addition the company used 81.47bn on investing activities and also paid 62.08bn in financing cash flows.
Cash flow per share | 132.81 |
---|---|
Price/Cash flow per share | 19.82 |
Book value per share | 955.29 |
---|---|
Tangible book value per share | 539.72 |
More ▼
Balance sheet in JPYView more
Current ratio | 2.98 |
---|---|
Quick ratio | 1.72 |
Total debt/total equity | 0.1373 |
---|---|
Total debt/total capital | 0.1207 |
More ▼
Growth rates in JPY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 10.00% and 20.16%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg) | 0.86% |
---|---|
Div growth rate (5 year) | 10.26% |
Payout ratio (TTM) | 27.79% |
EPS growth(5 years) | 6.37 |
---|---|
EPS (TTM) vs TTM 1 year ago | 32.30 |
More ▼